光フェレシス市場レポート：動向、予測、競合分析（～2031年）

世界の光フェレシス市場は、閉塞性細気管支炎症候群と再発性急性拒絶反応の市場に機会があり、将来性が期待されます。世界の光フェレシス市場は、2025年から2031年にかけてCAGR 5.7%で成長すると予想されています。この市場の主な促進要因は、自己免疫疾患の有病率の上昇、移植片対宿主病の症例の増加、非侵襲的治療オプションの需要です。

Lucintel社は、タイプ別では体外光フェレシスが予測期間中に最も高い成長を遂げると予測しています。

用途別では、再発性急性拒絶反応が高い成長を示すと予想されます。

地域別では、アジア太平洋が予測期間中に最も高い成長が見込まれます。

150ページを超える包括的なレポートから、ビジネス上の意思決定に役立つ貴重な洞察を得ることができます。いくつかの洞察を含むサンプル図を以下に示します。

光フェレシス市場の新たな動向

光フェレシス市場は、技術革新、患者需要の増加、進化するヘルスケアシステムにより主要動向が現れ、大きな変革期を迎えています。これらの動向は、世界中の光フェレシス治療の展望を再構築するのに役立っています。

• 光フェレシスデバイスの技術的進歩：よりコンパクトで、自動化され、患者に優しい光フェレシス装置の開発により、治療成績が向上しています。これらの進歩により、治療時間が短縮され、安全性が高まり、全体的な患者体験が向上しています。技術が進化し続けることで、光フェレシスはより身近で効率的なものになると期待されています。
• がんと自己免疫疾患に対する採用の拡大：光フェレシスは、CTCLのようながんやGVHDのような自己免疫疾患に対する効果的な治療法として認知されつつあります。この動向は、世界中の病院や診療所における光フェレシス療法の採用拡大につながっており、患者の転帰を改善し、市場の成長を拡大しています。
• 個別化治療オプションへの注目：個別化医療が増加する中、光フェレシス療法は、特にがん治療において、個々の患者のニーズに合わせて行われるようになってきています。この動向は、光フェレシス治療の精度と有効性を高めることに重点を置いており、各患者固有の状態や治療要件に適合することを保証しています。
• 外来光フェレシス治療へのシフト：病院やクリニックが外来で光フェレシス治療を提供することが増えており、患者にとってより便利になっています。このシフトは、より効率的な治療を可能にし、入院期間と関連コストを削減し、患者の満足度を向上させる光フェレシス装置の技術的進歩によってもたらされています。
• 新興市場への進出：光フェレシス市場は、先進医療への需要が高まっている新興国へと拡大しています。インドや中国などの国々では、慢性疾患の治療に光フェレシスの導入が進んでおり、これらの地域の市場に大きな成長機会をもたらしています。

このような新たな動向は、技術の進歩、アクセシビリティの向上、治療の精度の向上を促進し、光フェレシス市場を再構築しています。市場が成長するにつれ、特に新興経済圏では、個別化され、効率的で、外来患者に優しい光フェレシスの選択肢に対する需要が増加し、世界市場の大幅な成長に寄与すると予想されます。

光フェレシス市場の最近の動向

光フェレシス市場は、技術、臨床応用、患者ケアの著しい進歩に伴い、最近の動向は注目に値します。これらの開発は、特にがんや自己免疫疾患の治療など、様々な症状に対する効果的な治療法として光フェレシスの採用拡大に貢献しています。

• 新しい光フェレシスシステムのFDA承認米国FDAは最近、安全性が改善され、より効率的な処理を提供する新しい光フェレシス装置を承認しました。これらの承認は、特に血液がんや自己免疫疾患の治療における光フェレシスの普及を促進し、市場をさらに拡大しています。
• 光フェレシス研究のための新たなパートナーシップ：光フェレシス研究を推進するために、学術機関とヘルスケア企業との戦略的提携が増加しています。このような共同研究は、より効果的で正確な治療の開発に重点を置いており、標準的な治療レジメンへの光フェレシスの統合を加速するのに役立っています。
• 固形がんに対する光フェレシスの開発：光フェレシスは固形がんの治療にも応用されつつあり、従来の血液がんへの応用から大きく変化しています。初期段階の臨床試験では有望な結果が得られており、光フェレシスの使用がより幅広いがん治療に拡大する可能性があります。
• 外来診療における光フェレシスの成長：外来での光フェレシス治療は、技術の向上とともに一般的になりつつあります。ポータブルで効率的な装置の開発により、患者は外来で治療を受けられるようになり、利便性の向上とヘルスケアコストの削減が可能になりました。この動向は、世界中で光フェレシス治療の採用を促進すると予想されます。
• 光フェレシス業者の国際的拡大：光フェレシス装置の大手メーカー数社は、国際市場、特にアジアとラテンアメリカでの市場プレゼンスを拡大しています。これらの地域のヘルスケアシステムが発展するにつれて、光フェレシスを含む高度な治療に対する需要が増加しており、これがこれらの地域における市場成長の原動力となっています。

光フェレシス市場における最近の動向は、特に技術的進歩、臨床研究、より広範なアクセシビリティを通じて、その導入と有効性を高めています。このような変化は、光フェレシスを腫瘍学や自己免疫疾患治療における重要な治療オプションとして位置づけ、市場の継続的な成長と革新に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の光フェレシス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析（2019年～2031年）

• マクロ経済動向（2019～2024年）と予測（2025～2031年）
• 世界の光フェレシス市場の動向（2019～2024年）と予測（2025～2031年）
• 世界の光フェレシス市場：タイプ別
  • 体外光フェレシス
  • 白血球除去療法
  • 血漿交換
  • その他
• 世界の光フェレシス市場：用途別
  • 閉塞性細気管支炎症候群
  • 再発性急性拒絶反応
  • その他

第4章 市場動向と予測分析：地域別（2019年～2031年）

• 世界の光フェレシス市場：地域別
• 北米の光フェレシス市場
• 欧州の光フェレシス市場
• アジア太平洋の光フェレシス市場
• その他地域の光フェレシス市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の光フェレシス市場における成長機会：タイプ別
  • 世界の光フェレシス市場における成長機会：用途別
  • 世界の光フェレシス市場における成長機会：地域別
• 世界の光フェレシス市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界の光フェレシス市場の能力拡大
  • 世界の光フェレシス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Haemonetics
• Fresenius Kabi
• Terumo
• Macopharma
• Mallinckrodt Pharmaceuticals

The future of the global photopheresis market looks promising with opportunities in the bronchiolitis obliterans syndrome and recurrent acute rejection markets. The global photopheresis market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of autoimmune disease, increasing cases of graft-versus-host disease, and demand for non-invasive treatment options.

Lucintel forecasts that, within the type category, extracorporeal photopheresis is expected to witness the highest growth over the forecast period.

Within the application category, recurrent acute rejection is expected to witness higher growth.

In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Photopheresis Market

The photopheresis market is undergoing significant transformation, with key trends emerging due to innovations in technology, increasing patient demand, and evolving healthcare systems. These trends are helping to reshape the landscape of photopheresis treatment across the world.

• Technological Advancements in Photopheresis Devices: The development of more compact, automated, and patient-friendly photopheresis devices is improving treatment outcomes. These advancements reduce treatment times, increase safety, and enhance the overall patient experience. As the technology continues to evolve, it is expected to make photopheresis more accessible and efficient.
• Growing Adoption for Cancer and Autoimmune Diseases: Photopheresis is being increasingly recognized as an effective treatment for cancers like CTCL and autoimmune diseases such as GVHD. This trend is leading to greater adoption of photopheresis therapies in hospitals and clinics worldwide, improving patient outcomes and expanding market growth.
• Focus on Personalized Treatment Options: With personalized medicine on the rise, photopheresis is being tailored to individual patient needs, particularly in cancer care. This trend focuses on enhancing the precision and efficacy of photopheresis treatments, ensuring that they are suited to each patient's unique condition and treatment requirements.
• Shift toward Outpatient Photopheresis Procedures: Hospitals and clinics are increasingly offering outpatient photopheresis treatments, making it more convenient for patients. This shift is driven by technological advancements in photopheresis devices that enable more efficient treatments, reducing hospital stays and associated costs, and improving patient satisfaction.
• Expansion into Emerging Markets: The photopheresis market is expanding into emerging economies, where there is a growing demand for advanced medical treatments. Countries such as India and China are seeing increased adoption of photopheresis for treating chronic diseases, presenting a significant growth opportunity for the market in these regions.

These emerging trends are reshaping the photopheresis market by driving technological advancements, improving accessibility, and enhancing the precision of treatments. As the market grows, particularly in emerging economies, the demand for personalized, efficient, and outpatient-friendly photopheresis options is expected to increase, contributing to significant growth in the global market.

Recent Developments in the Photopheresis Market

The photopheresis market has seen notable developments in recent years, with significant advancements in technology, clinical applications, and patient care. These developments have contributed to the growing adoption of photopheresis as an effective treatment for a variety of conditions, particularly in the treatment of cancer and autoimmune diseases.

• FDA Approval of New Photopheresis Systems: The U.S. FDA has recently approved new photopheresis devices that offer improved safety features and more efficient processing. These approvals are driving the widespread adoption of photopheresis, particularly in the treatment of blood cancers and autoimmune conditions, which is expanding the market further.
• Emerging Partnerships for Photopheresis Research: There has been an increase in strategic partnerships between academic institutions and healthcare companies to advance photopheresis research. These collaborations are focused on developing more effective and precise treatments, helping to accelerate the integration of photopheresis into standard treatment regimens.
• Development of Photopheresis for Solid Tumors: Photopheresis is being explored for the treatment of solid tumors, a significant shift from its traditional use in blood cancers. Early-stage clinical trials have shown promising results, potentially expanding the use of photopheresis to a broader range of cancer treatments.
• Growth of Photopheresis in Outpatient Clinics: Outpatient photopheresis treatments are becoming more common as technology improves. With the development of more portable and efficient devices, patients can undergo treatment in outpatient settings, improving convenience and reducing healthcare costs. This trend is expected to drive the adoption of photopheresis therapy worldwide.
• International Expansion of Photopheresis Providers: Several leading photopheresis device manufacturers are expanding their market presence in international markets, particularly in Asia and Latin America. As healthcare systems in these regions evolve, there is increased demand for advanced treatments, including photopheresis, which is driving market growth in these areas.

Recent developments in the photopheresis market are enhancing its adoption and effectiveness, particularly through technological advancements, clinical research, and broader accessibility. These changes are positioning photopheresis as a vital treatment option in oncology and autoimmune disease care, contributing to the market's ongoing growth and innovation.

Strategic Growth Opportunities in the Photopheresis Market

The photopheresis market offers several growth opportunities across key applications, particularly in the treatment of cancers, autoimmune disorders, and other chronic conditions. As technology improves and adoption increases, new markets and applications are emerging, offering significant growth potential.

• Cancer Treatment Applications: Photopheresis is increasingly being adopted in the treatment of cancers, especially cutaneous T-cell lymphoma and graft-versus-host disease. The continued development of photopheresis technologies for cancer therapies presents a key growth opportunity, expanding treatment options for patients and increasing market demand.
• Autoimmune Disorder Treatment: Photopheresis has proven effective in treating autoimmune disorders like GVHD and scleroderma. As awareness of its efficacy grows, there is significant potential for expanded use in autoimmune disease management, particularly in regions with high prevalence, such as North America and Europe.
• Pediatric Applications: Photopheresis is gaining traction in pediatric applications for treating autoimmune diseases and certain cancers. As treatment regimens become more personalized and less invasive, photopheresis holds promise in offering children more manageable treatment options with fewer side effects.
• Outpatient Treatment Opportunities: As photopheresis devices become more compact and efficient, the potential for outpatient treatments increases. This development offers a strategic growth opportunity, allowing healthcare providers to offer more flexible and cost-effective treatment options for patients, improving patient satisfaction, and expanding market reach.
• Expanding Markets in Developing Regions: Emerging markets, such as India and China, are increasingly adopting advanced medical technologies like photopheresis. The growing healthcare infrastructure in these regions presents significant growth opportunities for photopheresis providers looking to expand their market presence and serve a growing patient base.

The photopheresis market is poised for substantial growth due to key strategic opportunities in cancer treatment, autoimmune disorders, and pediatric care. As technology advances and accessibility increases, particularly in outpatient settings and emerging markets, these growth areas will drive the market's expansion and enhance its role in global healthcare.

Photopheresis Market Driver and Challenges

The photopheresis market is influenced by various technological, economic, and regulatory drivers and challenges. These factors are shaping the growth of the market by influencing the adoption of photopheresis technology, its effectiveness, and its accessibility across different regions.

The factors responsible for driving the photopheresis market include:

1. Technological Advancements in Photopheresis Devices: The continuous development of more compact, efficient, and automated photopheresis devices is a major driver in the market. These advancements improve patient comfort, reduce treatment times, and increase the overall efficiency of photopheresis therapies, driving greater adoption in clinical settings.

2. Rising Incidence of Autoimmune Diseases and Cancers: An increase in the incidence of autoimmune diseases and cancers, especially hematologic malignancies, is driving the demand for photopheresis treatments. As these conditions become more prevalent, the need for effective treatment options like photopheresis grows, contributing to market expansion.

3. Government Support and Reimbursement Policies: Government initiatives and favorable reimbursement policies are encouraging healthcare providers to adopt photopheresis treatments. This support, especially in developed markets, ensures that photopheresis becomes more accessible to patients, fueling its market growth.

4. Growing Patient Preference for Non-invasive Treatments: Patients increasingly prefer non-invasive treatments like photopheresis over traditional methods such as chemotherapy or surgery. The rising demand for less invasive treatment options is a significant driver for photopheresis adoption, particularly for chronic conditions like autoimmune diseases.

5. Expanding Healthcare Infrastructure in Emerging Markets: Improving healthcare infrastructure in developing regions is opening new opportunities for photopheresis treatment. As hospitals and clinics in these regions invest in advanced technologies, the demand for photopheresis is expected to increase, contributing to market growth.

Challenges in the photopheresis market are:

1. High Treatment Costs: The high cost of photopheresis treatments, including the expense of devices and specialized procedures, remains a significant challenge. These costs can limit the adoption of photopheresis in lower-income regions and may hinder broader market expansion.

2. Efficacy Concerns and Limited Indications: Despite its effectiveness in certain conditions, the efficacy of photopheresis in treating other diseases is still being studied. Limited indications for use in non-cancerous conditions may slow the growth of the market, as more evidence is needed to justify its broader application.

3. Regulatory Hurdles and Approval Delays: The regulatory approval process for new photopheresis devices can be lengthy and complex, delaying market entry. Stringent regulations in different regions may slow the adoption of new technologies, which can impact market growth and innovation.

The major drivers of the photopheresis market include technological advancements, rising disease prevalence, and supportive government policies. However, challenges such as high treatment costs, limited indications, and regulatory hurdles must be overcome for the market to reach its full potential. Addressing these challenges will be key to sustaining growth in the photopheresis market.

List of Photopheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies photopheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the photopheresis companies profiled in this report include-

• Haemonetics
• Fresenius Kabi
• Terumo
• Macopharma
• Mallinckrodt Pharmaceuticals

Photopheresis Market by Segment

The study includes a forecast for the global photopheresis market by type, application, and region.

Photopheresis Market by Type [Value from 2019 to 2031]:

• Extracorporeal Photopheresis
• Leukapheresis
• Plasmapheresis
• Others

Photopheresis Market by Application [Value from 2019 to 2031]:

• Bronchiolitis Obliterans Syndrome
• Recurrent Acute Rejection
• Others

Photopheresis Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Photopheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. It highlights recent developments by major photopheresis producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., photopheresis technology is increasingly being used for treating conditions like cutaneous T-cell lymphoma (CTCL) and graft-versus-host disease (GVHD). Key players in the market are focusing on improving the efficiency and safety of photopheresis machines, as well as enhancing patient comfort during treatment.
• China: China is witnessing a surge in demand for photopheresis treatments, particularly for cancer and autoimmune diseases. The government's focus on improving healthcare infrastructure is driving the adoption of photopheresis technologies, and local manufacturers are increasingly involved in the production of photopheresis devices to meet the rising demand.
• Germany: Germany remains at the forefront of photopheresis technology in Europe. Research institutions in the country are developing more advanced systems for photopheresis, particularly targeting hematologic malignancies. The German healthcare system continues to support the integration of photopheresis as a treatment for various blood disorders, pushing forward innovation in the market.
• India: India is seeing rapid adoption of photopheresis in the treatment of conditions like skin diseases and certain types of cancers. Indian hospitals are increasingly investing in photopheresis devices, driven by a growing demand for advanced cancer and autoimmune treatments. This development is enhancing the treatment landscape in the country.
• Japan: In Japan, photopheresis is gaining popularity for treating conditions such as lymphoma and autoimmune disorders. Japan's focus on advancing medical technologies is boosting the market, with local companies developing innovative photopheresis systems that emphasize patient comfort, treatment efficiency, and safety.

Features of the Global Photopheresis Market

Market Size Estimates: Photopheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Photopheresis market size by type, application, and region in terms of value ($B).

Regional Analysis: Photopheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the photopheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the photopheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the photopheresis market by type (extracorporeal photopheresis, leukapheresis, plasmapheresis, and others), application (bronchiolitis obliterans syndrome, recurrent acute rejection, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Photopheresis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Photopheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Photopheresis Market by Type
  • 3.3.1: Extracorporeal Photopheresis
  • 3.3.2: Leukapheresis
  • 3.3.3: Plasmapheresis
  • 3.3.4: Others
• 3.4: Global Photopheresis Market by Application
  • 3.4.1: Bronchiolitis Obliterans Syndrome
  • 3.4.2: Recurrent Acute Rejection
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Photopheresis Market by Region
• 4.2: North American Photopheresis Market
  • 4.2.1: North American Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.2.2: North American Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.3: European Photopheresis Market
  • 4.3.1: European Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.3.2: European Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.4: APAC Photopheresis Market
  • 4.4.1: APAC Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.4.2: APAC Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.5: ROW Photopheresis Market
  • 4.5.1: ROW Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.5.2: ROW Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Photopheresis Market by Type
  • 6.1.2: Growth Opportunities for the Global Photopheresis Market by Application
  • 6.1.3: Growth Opportunities for the Global Photopheresis Market by Region
• 6.2: Emerging Trends in the Global Photopheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Photopheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Photopheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Haemonetics
• 7.2: Fresenius Kabi
• 7.3: Terumo
• 7.4: Macopharma
• 7.5: Mallinckrodt Pharmaceuticals